ヘプタデカフルオロ-n-オクチルブロミド

Perfluorooctyl bromide

HCID 9873CAS 423-55-2

基本情報

標準SMILES
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br
InChIKey
WTWWXOGTJWMJHI-UHFFFAOYSA-N
分子式
C8BrF17
平均分子量
498.96 g/mol
単同位体質量
497.89119

名称と識別子

優先名称
Perfluorooctyl bromide
IUPAC
1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane
現地名
ヘプタデカフルオロ-n-オクチルブロミド
英語名
1-BroMoheptadecafluorooctane
分子式
C8BrF17
分子量
498.96

名称と別名

Perflubron423-55-21-BromoperfluorooctanePerfluorooctyl bromide1-BromoheptadecafluorooctanePerfluoroctyl bromide1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctanePerfluorooctylbromidePFOBN-perfluorooctyl bromideperfluorocaprylyl bromideDTXSID5046560
名称をさらに表示
ヘプタデカフルオロ-n-オクチルブロミドペルフルブロンイマゲントヘプタデカフルオロオクチルブロミドイマジェント1-ブロモ-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-ヘプタデカフルオロオクタンヘプタデカフルオロ-1-ブロモオクタン1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-ヘプタデカフルオロ-1-ブロモオクタンF-オクチルブロミド1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-ヘプタデカフルオロ-8-ブロモオクタンペルフルオロオクチルブロミド1-ブロモヘプタデカフルオロオクタン1-ブロモパーフルオロオクタン1-ブロモパーフルオロオクタン, 98+%パーフルブロンパーフルオロオクチルブロミドImagentHEPTADECAFLUORO-N-OCTYL BROMIDETBr-8uorooctanelong’scompound
OCTANE, 1-BROMOHEPTADECAFLUORO-Q1D0Q7R4D9Octane, 1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-DTXCID3026560CHEBI:38803perfluoroctylbromideperflubronumperfluorooctyliodide

データベース識別子

CAS
423-55-2
PubChem CID
9873
DTXSID
DTXSID5046560
ChEMBL
CHEMBL1200866
ChEBI
CHEBI:38803
UNII
Q1D0Q7R4D9
EC Number
207-028-4
Nikkaji
J94.754G

物性

構造計算による物性

XLogP
6.9
極性表面積
0 Ų
水素結合供与体数
0
水素結合受容体数
17
回転可能結合数
6
重原子数
26

実験および物理化学的性質

Kovats Retention Index581

物理化学的性質

融点
6 °C · 6 °C
沸点
142 °C · 142 °C(lit.)
比重(密度)
1.93 g/mL · 1.93 g/mL at 25 °C(lit.)
蒸気圧
12.8 · 12.8-72hPa at 25-65℃
屈折率
20 · n20/D 1.305(lit.)
闪点
141 · 141-143°C

化学的性質

化学的特性clear colorless liquid

安全と法規制

GHS分類

GHS Classification · 6 件

Warning

H315 (90.9%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (90.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (89.1%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

H413: May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]

危険有害性情報

Regulatory InformationStatus: Active Update: 22-10-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/23055
Hazard Classes and Categories · 2 件

Skin Irrit. 2 (90.9%);Eye Irrit. 2 (90.9%);STOT SE 3 (89.1%)

Hazardous to the aquatic environment (Long-term) - Category 4

法規制情報

Regulatory InformationStatus: Active Update: 22-10-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/23055

安全データ

wgk
3
rtecs
RG8700000
ridadr
2810
毒性
LD50 i.v. in female rats: 41 g/kg (Burgan)
hs_code
29037800
risk_code
36/37/38

化学と産業

薬理情報

ATC Code · 2 件

V - Various;V08 - Contrast media;V08C - Magnetic resonance imaging contrast media;V08CX - Other magnetic resonance imaging contrast media;V08CX01 - Perflubron

QV - Various;QV08 - Contrast media;QV08C - Magnetic resonance imaging contrast media;QV08CX - Other magnetic resonance imaging contrast media;QV08CX01 - Perflubron

Mechanism of Action · 1 件

Perflubron emulsion (Oxygent) maintains hemodynamic stability during major surgery, thereby potentially reducing or avoiding intraoperative transfusions of donor blood in major surgery.Perflubron emulsion has ability to enable patients to be physiologically stable and safe at lower intraoperative Hb levels.

MeSH Pharmacological Classification · 3 件

Substances used to allow enhanced visualization of tissues.

Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.

Agents that increase energy expenditure and weight loss by neural and metabolic regulation.

用途と製造

Uses · 2 件

• Ophthalmology [Ref: https://doi.org/10.1155/2014/250323];• Oxygen carrier for artificial blood [Ref: https://doi.org/10.1039/c7gc03081a];• Solvent for printing ink [Ref: CAS2019 (CN109810567)];• X-ray imaging [Ref: https://doi.org/10.1007/978-1-4899-1202-2];• Supply of gases, including CO2, to microbial cells [Ref: https://doi.org/10.1007/978-1-4899-1202-2]

non-polymer PFAS -> Printing (Inks) -> Toner and printer inks;non-polymer PFAS -> Pharmaceutical Industry -> Processing aid in the manufacture of “microporous” particles;non-polymer PFAS -> Medicinal Utensils -> Retinal detachment surgery and proliferative vitreoretinopathy;non-polymer PFAS -> Medicinal Utensils -> Supplement conventional blood transfusion and artificial blood and perfusion of isolated organs;non-polymer PFAS -> Medicinal Utensils -> Contrast agent;non-polymer PFAS -> Biotechnology -> Supply of oxygen and other gases to cells in culture

Use ClassificationPFAS (per- and polyfluoroalkyl substances) -> OECD Category
応用分野 · 3 件

用途有機合成原料。

使用1-BroMoheptadecafluorooctane can be used as oxygen carrier in emulsions used as blood substitutes.

一般的な説明1-Bromoheptadecafluorooctane (perfluorooctyl bromide) is a perfluorocarbon. Poly(ethylene glycol)ylated polyester nanocapsules of perfluorooctyl bromide were surface-decorated with a RGD (arginine-glycine-aspartic acid) peptide, were used for tumor imaging. Nanocapsules of perfluorooctyl bromide have been developed as dual contrast agent for ultrasonography and Magnetic Resonance Imaging (MRI).

サプライヤー50 社

国药集团化学试剂有限公司86-21-63210123 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
江西核研院新材料有限公司18901398682 18901398682 · [email protected]
上海比阳实业有限公司+86-21-52699951; +8613917686115 · [email protected]

関連反応

8 件

関連ノート

読み込み中…